OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy
Jinjing Wei, Yongting Zhao, Haihai Liang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 1-17
Open Access | Times Cited: 69
Jinjing Wei, Yongting Zhao, Haihai Liang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 1-17
Open Access | Times Cited: 69
Showing 1-25 of 69 citing articles:
ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage
Xiaohui Ma, Jiang-Han-Zi Liu, Chunyu Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 142
Xiaohui Ma, Jiang-Han-Zi Liu, Chunyu Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 142
6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway
Shenglin Wu, Jinxiu Zhu, Guihai Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 81
Shenglin Wu, Jinxiu Zhu, Guihai Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 81
Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53
Yuan-juan Tang, Zhen Zhang, Yan Tong, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 28
Yuan-juan Tang, Zhen Zhang, Yan Tong, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 28
Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases
Haowen Xu, Jiahao Chen, Pan Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 678-693
Open Access | Times Cited: 57
Haowen Xu, Jiahao Chen, Pan Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 678-693
Open Access | Times Cited: 57
Different types of cell death in diabetic endothelial dysfunction
Jieru Shen, Wenqing San, Yangyang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115802-115802
Open Access | Times Cited: 37
Jieru Shen, Wenqing San, Yangyang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115802-115802
Open Access | Times Cited: 37
Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36 ‐mediated ferroptosis
Xin Li, Ziwei Li, Xin Dong, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 7, pp. 3042-3056
Closed Access | Times Cited: 32
Xin Li, Ziwei Li, Xin Dong, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 7, pp. 3042-3056
Closed Access | Times Cited: 32
Bmal1 downregulation leads to diabetic cardiomyopathy by promoting Bcl2/IP3R-mediated mitochondrial Ca2+ overload
Nannan Zhang, Hao Yu, Tianzi Liu, et al.
Redox Biology (2023) Vol. 64, pp. 102788-102788
Open Access | Times Cited: 27
Nannan Zhang, Hao Yu, Tianzi Liu, et al.
Redox Biology (2023) Vol. 64, pp. 102788-102788
Open Access | Times Cited: 27
Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy
Dan Ke, Zhen Zhang, Jieting Liu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 23
Dan Ke, Zhen Zhang, Jieting Liu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 23
Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
Ferroptosis Contributes to Microvascular Dysfunction in Diabetic Retinopathy
Qun Liu, Chaoqun Liu, Wan-Zhao Yi, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 6, pp. 1078-1089
Closed Access | Times Cited: 10
Qun Liu, Chaoqun Liu, Wan-Zhao Yi, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 6, pp. 1078-1089
Closed Access | Times Cited: 10
Role of pyroptosis in diabetic cardiomyopathy: an updated review
Gan Wang, Tianyi Ma, Kang Huang, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 9
Gan Wang, Tianyi Ma, Kang Huang, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 9
LncRNA as a regulator in the development of diabetic complications
Mengrou Geng, Wei Liu, Jinjie Li, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 8
Mengrou Geng, Wei Liu, Jinjie Li, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 8
Therapeutic Potential of Curcumin in Diabetic Cardiomyopathy: Modulation of Pyroptosis Pathways
Fei Wang, Lehan Liu, Jiaxin Wang, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access | Times Cited: 1
Fei Wang, Lehan Liu, Jiaxin Wang, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access | Times Cited: 1
TiOx(OH)4–2x Nanosheets with Catalytic Antioxidative Activity Alleviate Oxidative Injury in Diabetic Cardiomyopathy
Y. Yao, Bowen Yang, Jianlin Shi
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Y. Yao, Bowen Yang, Jianlin Shi
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR‑18a‑3p/Gsdmd pathway
Lin Yang, Chunfeng Cheng, Zhifang Li, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 6
Closed Access | Times Cited: 22
Lin Yang, Chunfeng Cheng, Zhifang Li, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 6
Closed Access | Times Cited: 22
Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway
Fan Li, Zhenfei Hu, Yidan Huang, et al.
Journal of Cardiothoracic Surgery (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 17
Fan Li, Zhenfei Hu, Yidan Huang, et al.
Journal of Cardiothoracic Surgery (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 17
Role of RIPK3‑CaMKII‑mPTP signaling pathway‑mediated necroptosis in cardiovascular diseases (Review)
Sheng Chen, Senhong Guan, Zhaohan Yan, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 4
Open Access | Times Cited: 17
Sheng Chen, Senhong Guan, Zhaohan Yan, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 4
Open Access | Times Cited: 17
Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy
Songren Shu, Hao Cui, Zirui Liu, et al.
Metabolism (2024) Vol. 158, pp. 155977-155977
Open Access | Times Cited: 7
Songren Shu, Hao Cui, Zirui Liu, et al.
Metabolism (2024) Vol. 158, pp. 155977-155977
Open Access | Times Cited: 7
Baicalin Attenuates Diabetic Cardiomyopathy In Vivo and In Vitro by Inhibiting Autophagy and Cell Death Through SENP1/SIRT3 Signaling Pathway Activation
Peipei Zhang, Haowei Wu, Haifei Lou, et al.
Antioxidants and Redox Signaling (2024)
Closed Access | Times Cited: 6
Peipei Zhang, Haowei Wu, Haifei Lou, et al.
Antioxidants and Redox Signaling (2024)
Closed Access | Times Cited: 6
PANoptosis: a novel target for cardiovascular diseases
Q. Xiang, Zhen-Xi Geng, Xin Yi, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 8, pp. 739-756
Closed Access | Times Cited: 6
Q. Xiang, Zhen-Xi Geng, Xin Yi, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 8, pp. 739-756
Closed Access | Times Cited: 6
MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes
Ting Cao, Rui Ni, Weimin Ding, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Ting Cao, Rui Ni, Weimin Ding, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Salidroside facilitates therapeutic angiogenesis in diabetic hindlimb ischemia by inhibiting ferroptosis
Yi‐Cheng Wang, Jingxuan Han, Lailiu Luo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114245-114245
Open Access | Times Cited: 15
Yi‐Cheng Wang, Jingxuan Han, Lailiu Luo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114245-114245
Open Access | Times Cited: 15
Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
Huiyan Sun, Dandan Chen, Wenjing Xin, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Huiyan Sun, Dandan Chen, Wenjing Xin, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Propofol and salvianolic acid A synergistically attenuated cardiac ischemia–reperfusion injury in diabetic mice via modulating the CD36/AMPK pathway
Jiaqi Zhou, Weiyi Xia, Jiajia Chen, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 5
Jiaqi Zhou, Weiyi Xia, Jiajia Chen, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 5
Ferroptosis and Traditional Chinese Medicine for Type 2 Diabetes Mellitus
Dandan Xie, Kai Li, R. Feng, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1915-1930
Open Access | Times Cited: 11
Dandan Xie, Kai Li, R. Feng, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1915-1930
Open Access | Times Cited: 11
